Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Non Randomized, Single Arm Study to Evaluate Safety of Transarterial Chemoembolization (TACE) With Doxorubicin Eluting 100 µ Microspheres in Patients With Non Resectable Hepatocellular Carcinoma

NCT02670122 is registered in ClinicalTrials.gov with Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz as lead sponsor.

NCT NCT02670122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02670122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Non Randomized, Single Arm Study to Evaluate Safety of Transarterial Chemoembolization (TACE) With Doxorubicin Eluting 100 µ Microspheres in Patients With Non Resectable Hepatocellular Carcinoma
Lead sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Phase
Observational
Overall status
Completed
Start date
March 31, 2015
Completion date
November 30, 2018
Enrollment
131 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma